BioHealth News Archive
Cerecor Announces Positive Initial Phase 1b Results for CERC-002 in Moderate to Severe Crohn’s Disease Patients
ROCKVILLE, Md. and CHESTERBROOK, Pa., July 26, 2021 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in…
Read MoreCheck-out JLABS quarterly portfolio update
Each quarter we bring you an update from our Johnson & Johnson Innovation – JLABS Portfolio of ompanies across our 13 sites, from San Diego…
Read MoreImmunomic Therapeutics Expands Board of Directors with Appointments of Two New Members – Immunomic Therapeutics
ROCKVILLE, Md.–(BUSINESS WIRE)–Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, announced today that it…
Read MoreMason’s Michael Buschmann and team at start-up AexeRNA Therapeutics Inc. pursue patents for improved COVID-19 vaccines
George Mason University bioengineering professor Michael Buschmann and a team of scientific collaborators have devised improved lipid nanoparticle technologies to deliver mRNA that could…
Read MoreNew Collaboration Aims to Improve Measurement of Viral Vectors Used in Cutting-Edge Gene Therapies
A large interlaboratory study of adeno-associated virus (AAV), an important tool in gene therapy, will be led by USP and NIST in collaboration with…
Read MoreMaxCyte Announces Launch of Offering and Application to List on the Nasdaq Global Market
GAITHERSBURG, Md., July 26, 2021 /PRNewswire/ -- MaxCyte, Inc., (LSE: MXCT) (LSE: MXCN), a leading provider of platform technologies for cell engineering, today announced…
Read MoreJeff Boyle, President of Ellume USA, joins Rich Bendis on BioTalk
Jeff Boyle, President of Ellume USA, joins Rich Bendis on BioTalk to chat about his history, their Flagship U.S. Manufacturing Facility in Frederick, MD,…
Read MoreThe NIH’s Investment in Biotech Ecosystems | Bioeconomy.XYZ
The US National Institutes of Health (NIH) are the largest public supporter of basic life science in the world. With an FY2020 budget of…
Read MoreMontgomery County Updates: County Welcomes BioNTech to Gaithersburg for U.S. Manufacturing Facility
German-based BioNTech has announced that it will soon be joining Montgomery County’s growing list of world-renowned international companies in the “Immunology Capital Next to…
Read MorePreparing for the Endless Frontier: What Universities, States and Regions Should Do Now While Congress Finalizes Its Plans?
The Endless Frontier bill, now incorporated into the U.S. Innovation and Competition Act, made progress in the U.S. Senate while parallel legislation in the…
Read MoreSponsored | The essential guide to drug commercialization: A manufacturer’s handbook for selecting solutions and partners | BioSpace
You have invested the time, expertise, and financial resources to develop a therapy that changes patient lives for the better. After all of your…
Read MoreMatan Companies breaks ground on Progress Labs at Riverside
Matan Companies breaks ground on Progress Labs at Riverside I The City-based project will feature 215,000 square feet of biomanufacturing-ready space -- including a…
Read MoreHIV Cure Program Releases Initial Clinical Trial Data | American Gene Technologies
ROCKVILLE, MD, July 15, 2021 /Globe Newswire/ -- American Gene Technologies (AGT) announced today that the Data and Safety Monitoring Board (DSMB) voted unanimously…
Read MoreEmergent BioSolutions wins extension on smallpox vaccine deal – Baltimore Business Journal
The extension follows a tumultuous time for the Gaithersburg company, making it unclear if the government would proceed with deals as normal. {iframe}https://www.bizjournals.com/baltimore/news/2021/07/21/emergent-biolsolutions-wins-smallpox-vaccine-deal.html{/iframe}
Read MoreCovid vaccine maker BioNTech buys Gaithersburg manufacturing facility – Washington Business Journal
The German firm hopes to expand its cancer treatments with the purchase. Image: BioNTech is buying a Gaithersburg manufacturing facility on Clopper Road from…
Read More